Leora Horn COSA 2015 ASM

Abstracts this author is presenting:

• Longer-term follow-up of a phase 2 study (CheckMate 063) of nivolumab in patients with advanced refractory squamous (SQ) non-small cell lung cancer (NSCLC) — Posters1